Optimal Vaccine Centers of Excellence (OVCoE)

Our global vaccine site conduct organization supercharged with accelerated patient enrollment, advanced lab capabilities, and specialized vaccine services – delivered under a result-based contracting model for greater budget certainty.

Superior, standardized quality

Powered by SOPs, processes, training.

  • Expansion of Optimal Vaccine capabilities and Synexus sites into Optimal Vaccine Centers of Excellence.
  • Specialized vaccine sites with advanced lab capabilities.
  • Proven recruitment strategies to provide greater enrollment certainty on a vaccine study.
  • Delivery of needed patients with dedicated vaccine sites and in less time using patient-centered approach.
  • Enhanced, global vaccine site services business.
  • SOPs: Optimal capabilities and SOPs adhered to by all core sites. Reviewed by QA, Medical, and Clinical Operations.
  • Training: OVCoE sites complete intensive internal and external training programs.
 

Budget certainty

Results-based commercial terms for peace of mind.

  • All site and enrollment fees rolled into one price per patient, including investigator grants, procedural fees, and recruiting fees.
  • No setup fees.
  • Capped budgets with the potential for bonus/ penalty terms.
  • Simplified and centralized contracting across all sites to increase speed of study start-up and maximize site footprint from day one.
  • Greater cost and time certainty in trial delivery.

Working together to deliver superior enrollment rates and trial productivity.

Why OVCoE?

Over

70K

patients recruited to vaccine trials

Over

850

vaccine studies performed

Over

1,600

Infectious Disease and Vaccine studies conducted, representing over 500 different protocols

Over

21,000

subjects randomized into Infectious Disease trials

Our Experience

  • Full-time specialists in vaccine clinical trials.
  • Proven recruitment strategies to provide greater enrollment certainty on a vaccine study.
  • On-site PBMC processing capabilities with high recovery and viability.
  • Experienced with various modes of vaccine delivery and government funded programs and stipulations.

Our Comprehensive Site Services Business

  • Key dedicated research sites selected based on vaccine capabilities and experience in vaccine clinical studies, level of interest, and equipment present at the sites chosen.
  • You can add KOLs and other sites as desired.